Solid Biosciences Inc
SLDB
Get informed when a big investor buys or sells
+ FollowMarket Cap$825.99M
Close$
$0.44
95.1% downside
Current Fair Value
95.1% downsideOvervalued by 95.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $825.99 Million |
|---|---|
| Enterprise Value | $686.75 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.99 |
| Beta | 2.36 |
| Outstanding Shares | 143,688,701 |
Return
| Return on Equity | -55.36% |
|---|---|
| Return on Assets | -49.24% |
| Return on Invested Capital | -53.46% |
Valuation & Multiples
| P/E Ratio | -4.39 |
|---|---|
| PEG | -11.32 |
| Price to Sales | - |
| Price to Book Ratio | 4.54 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.28 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 47.33% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.14%▼ 79.65% |
|---|---|
| Total Invested | $122.19M▼ 82.97% |
| Investors Holding | 37▼ 112.00% |
ESG Score
No data